Development and validation of an integrativepan-solid tumor predictor of PD-1PD-L1blockade benefit

Article by communications medicine

To read the article click the link below

By Scott A. Tomlins , Nickolay A. Khazanov, Benjamin J. Bulen1, Daniel H. Hovelson, Melissa J. Shreve ,

Laura E. Lamb, Marc R. Matrana, Mark E. Burkard, Eddy Shih-Hsin Yang, William Jeffery Edenfield,

E. Claire Dees, Adedayo A. Onitilo, Michael Thompson , Gary L. Buchschacher Jr, Alan M. Miller,

Alexander Menter, Benjamin Parsons, Timothy Wassenaar, Leon C. Hwang, J. Marie Suga,

Robert Siegel, William Irvin Jr, Suresh Nair, Jennifer N. Slim, Jamal Misleh, Jamil Khatri,

Gregory Masters, Sachdev Thomas, Malek Safa, Daniel M. Anderson, Kat Kwiatkowski,

Khalis Mitchell , Tina Hu-Seliger, Stephanie Drewery, Andrew Fische, Komal Plouffe, Eric Czuprenski,

Jennifer Hipp, Travis Reeder, Hana Vakil, D. Bryan Johnson & Daniel R. Rhodes

Recent Posts